These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18720359)

  • 1. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
    Saad AG; Yeap BY; Thunnissen FB; Pinkus GS; Pinkus JL; Loda M; Sugarbaker DJ; Johnson BE; Chirieac LR
    Cancer; 2008 Oct; 113(8):2129-38. PubMed ID: 18720359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
    Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
    Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
    Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs.
    Gui Q; Liu J; Li D; Xu C
    World J Surg Oncol; 2017 Oct; 15(1):184. PubMed ID: 29037198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
    Yu X; Sheng J; Pan G; Fan Y
    Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B; Pappot H; Holmstav J; Skov BG
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.
    Sun M; Behrens C; Feng L; Ozburn N; Tang X; Yin G; Komaki R; Varella-Garcia M; Hong WK; Aldape KD; Wistuba II
    Clin Cancer Res; 2009 Aug; 15(15):4829-37. PubMed ID: 19622585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model.
    Yoo JY; Yang SH; Lee JE; Cho DG; Kim HK; Kim SH; Kim IS; Hong JT; Sung JH; Son BC; Lee SW
    J Neurooncol; 2012 Sep; 109(2):219-27. PubMed ID: 22576972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small-cell Lung Cancer With Brain Metastasis at Presentation.
    Waqar SN; Samson PP; Robinson CG; Bradley J; Devarakonda S; Du L; Govindan R; Gao F; Puri V; Morgensztern D
    Clin Lung Cancer; 2018 Jul; 19(4):e373-e379. PubMed ID: 29526531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.
    Sun D; Li X; Ma M; Liu J; Xu Y; Ye L; Hou H; Wang C; Li X; Jiang Y
    Jpn J Clin Oncol; 2015 May; 45(5):464-73. PubMed ID: 25646356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes.
    Del Gobbo A; Morotti A; Colombo AE; Vaira V; Ercoli G; Pesenti C; Bonaparte E; Guerini-Rocco E; Di Cristofori A; Locatelli M; Palleschi A; Ferrero S
    Med Oncol; 2017 Dec; 35(1):2. PubMed ID: 29209838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
    Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
    Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial.
    Dohm A; Su J; McTyre ER; Taylor JM; Miller LD; Petty WJ; Xing F; Lo HW; Metheny-Barlow LJ; O'Neill S; Bellinger C; Dotson T; Pasche B; Watabe K; Chan MD; Ruiz J
    Int J Biol Markers; 2019 Mar; 34(1):90-97. PubMed ID: 30854931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
    Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
    Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
    Bubb RS; Komaki R; Hachiya T; Milas I; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1216-24. PubMed ID: 12128123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
    Dinglin XX; Ma SX; Wang F; Li DL; Liang JZ; Chen XR; Liu Q; Zeng YD; Chen LK
    Clin Lung Cancer; 2017 May; 18(3):e179-e186. PubMed ID: 28185793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.